01515oam 2200385Ia 450 991069038100332120230902161638.0(CKB)5470000002337480(OCoLC)496287106(EXLCZ)99547000000233748020100108d1995 ua 0enguran|||||||||txtrdacontentcrdamediacrrdacarrierGuidance for industry[electronic resource] content and format of investigational new drug applications (INDs) for phase 1 studies of drugs, including well-characterized, therapeutic, biotechnology-derived products[Rockville, MD] :Center for Drug Evaluation and Research :Center for Biologics Evaluation and Research,[1995]1 online resource (i, 16 pages)"November 1995."Includes bibliographical references (pages 15-16).Guidance for industry DrugsTestingGovernment policyUnited StatesPharmaceutical biotechnologyGovernment policyUnited StatesDrugsTestingGovernment policyPharmaceutical biotechnologyGovernment policyCenter for Drug Evaluation and Research (U.S.)Center for Biologics Evaluation and Research (U.S.)GPOGPOGPOBOOK9910690381003321Guidance for industry3434577UNINA